-+ 0.00%
-+ 0.00%
-+ 0.00%

Accendra Health names Kenneth Gardner-Smith as next CEO, effective Q4 2026

PUBT·09/17/2026 10:30:42
Listen to the news
Accendra Health names Kenneth Gardner-Smith as next CEO, effective Q4 2026
  • Accendra Health named Kenneth Gardner-Smith president and CEO, effective early Q4 2026, succeeding Edward A. Pesicka on his retirement.
  • Gardner-Smith is CEO of Veritas Veterinary Partners; previously held operating roles at DaVita, including managing $1.5 billion in operations.
  • Pesicka will retire from the board when the CEO transition takes effect, remaining an advisor during the handover.
  • Gardner-Smith will stay on the board as a non-independent director, stepping down from the Our People & Culture Committee, Audit Committee.
  • Scott Lloyd was appointed chief commercial officer effective Oct. 5, 2026; he co-founded Extrakare, most recently led development, strategy at Evergreen Nephrology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accendra Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609170630BIZWIRE_USPR_____20260917_BW344754) on September 17, 2026, and is solely responsible for the information contained therein.